Mark Webster

PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS

Mark Webster, H. Smith, D. N. Sharpe et al. · The Lancet · 1988 · 826 citations

Thrombosis, Interventional Neuroradiology, Medicine +6

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

Patrick W. Serruys, John A. Ormiston, Yoshinobu Onuma et al. · The Lancet · 2009 · 816 citations

Percutaneous Coronary Intervention, Cardiovascular Translational Research, Cardiovascular Disease +10

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

John A. Ormiston, Patrick W. Serruys, Evelyn Regar et al. · The Lancet · 2008 · 714 citations

Percutaneous Coronary Intervention, Prospective Open-label Trial, Cardiovascular Disease +6

RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS

Mark Richards, Hamid Ikram, Timothy G. Yandle et al. · The Lancet · 1985 · 402 citations

Hypertension, Cardiovascular Disease, Medicine +6

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.

M. Heras, James H. Chesebro, Mark Webster et al. · Circulation · 1990 · 225 citations

Pharmacotherapy, Platelet-mediated Thrombosis, Thrombosis +19